Description

Sodium Phenylbutyrate (CAS No. 1716-12-7) is a highly refined pharmaceutical-grade compound with the molecular formula C₁₀H₁₁NaO₂. This white to off-white crystalline powder is widely recognized for its therapeutic applications in urea cycle disorders (UCDs) and ongoing research in neurodegenerative diseases. As a prodrug of phenylacetate, it facilitates the excretion of excess nitrogen via an alternative pathway. Our product meets stringent pharmacopeial standards (USP/EP) and is supplied with comprehensive analytical documentation (CoA, HPLC purity ≥98%). Ideal for clinical, research, and formulation development, it exhibits excellent solubility in water (500 mg/mL) and ethanol. Available in bulk quantities with customizable packaging under inert atmosphere to ensure stability.

Properties

• CAS Number: 1716-12-7
• Complexity: 142
• IUPAC Name: sodium;4-phenylbutanoate
• InChI: InChI=1S/C10H12O2.Na/c11-10(12)8-4-7-9-5-2-1-3-6-9;/h1-3,5-6H,4,7-8H2,(H,11,12);/q;+1/p-1
• InChI Key: VPZRWNZGLKXFOE-UHFFFAOYSA-M
• Exact Mass: 186.06567387
• Molecular Formula: C10H11NaO2
• Molecular Weight: 186.18
• SMILES: C1=CC=C(C=C1)CCCC(=O)[O-].[Na+]
• Topological: 40.1
• Monoisotopic Mass: 186.06567387
• Synonyms: SODIUM PHENYLBUTYRATE, 1716-12-7, sodium 4-phenylbutanoate, Buphenyl, Benzenebutanoic acid, sodium salt, Ammonaps, Pheburane, 4PBA, OLPRUVA, NSC 657802, UNII-NT6K61736T, ACER-001, CHEBI:75316, NT6K61736T, NSC-657802, AMX0035 COMPONENT SODIUM PHENYLBUTYRATE, SODIUM PHENYLBUTYRATE (MART.), SODIUM PHENYLBUTYRATE [MART.], SODIUM PHENYLBUTYRATE (USP-RS), SODIUM PHENYLBUTYRATE [USP-RS], SODIUM PHENYLBUTYRATE (EP MONOGRAPH), SODIUM PHENYLBUTYRATE [EP MONOGRAPH], SODIUM PHENYLBUTYRATE (USP MONOGRAPH), SODIUM PHENYLBUTYRATE [USP MONOGRAPH], KRISOSPB-8696, Sodium Phenylbutyrate Tablets, 500 mg, Sodium 4-phenylbutyrate, TriButyrate, sodium;4-phenylbutanoate, 4-phenylbutyric acid, sodium salt, MFCD00800247, DTXSID7040948, 4-phenylbutyric acid sodium, DTXCID5020948, Sodium phenylbutyrate [USAN], CAS-1716-12-7, Sodium phenylbutyrate; Sodium 4-phenylbutanoate, NCGC00018113-03, Ammonapse, Lunaphen, NaPb, Phenylbutyrate Na, Sodium phenylbutyrate [USAN:BAN], Buphenyl (TN), EL-532, VP-101, 4-Phenylbutyric acid sodium 100 microg/mL in Acetonitrile:Water, Sodium 4-phenylbutanoate, CHEMBL1746, Phenylbutyric acid sodium salt, SCHEMBL125792, Sodium 4-phenylbutyrate, 95%, CMK-304, Sodium phenylbutyrate (JAN/USP), HMS2089B22, HMS3269N07, HMS3413B10, HMS3652K18, HMS3677B10, HMS3885P05, HMS5082E18, SODIUM PHENYLBUTYRATE [MI], SODIUM PHENYLBUTYRATE [JAN], 4-Phenylbutyric acid sodium;4-PBA, Sodium 4-phenylbutyrate (Standard), Sodium 4-phenylbutyrate;TriButyrate, Tox21_110826, HY-15654R, PHENYLBUTYRATE SODIUM [VANDF], s4125, AKOS006344763, AKOS015967141, SODIUM PHENYLBUTYRATE [WHO-DD], Tox21_110826_1, CCG-213730, CCG-265014, CS-1397, IS58073, SODIUM PHENYLBUTYRATE [EMA EPAR], Sodium phenylbutyrate, >=98% (HPLC), NCGC00018113-07, NCGC00167830-01, AS-13914, HY-15654, SY067225, SODIUM PHENYLBUTYRATE [ORANGE BOOK], ALBRIOZA component SODIUM PHENYLBUTYRATE, NS00078686, O0511, SW219199-1, D05868, EN300-708769, F14969, RELYVRIO COMPONENT SODIUM PHENYLBUTYRATE, AMX-0035 COMPONENT SODIUM PHENYLBUTYRATE, Q7553358, Sodium phenylbutyrate, European Pharmacopoeia (EP) Reference Standard, Sodium phenylbutyrate, United States Pharmacopeia (USP) Reference Standard

Sodium Phenylbutyrate is primarily used as a nitrogen-binding agent for treating urea cycle disorders like ornithine transcarbamylase deficiency. It demonstrates promising neuroprotective effects in preclinical studies for ALS and Huntington’s disease through histone deacetylase inhibition. Recent clinical applications include combination therapies for cystic fibrosis and cancer research due to its chaperone-like protein folding modulation properties.

Safety and Hazards

GHS Hazard Statements

• H319 (93.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

Precautionary Statements

• P264+P265, P280, P305+P351+P338, and P337+P317

Hazard Classes and Categories

• Eye Irrit. 2 (93.2%)

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.